- Home
- GXO vs PCVX Comparison
GXO vs PCVX Comparison
Compare GXO & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GXO | PCVX |
|---|---|---|
| Founded | 2021 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 6.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | GXO | PCVX |
|---|---|---|
| Price | $56.71 | $49.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 7 |
| Target Price | $64.17 | ★ $105.00 |
| AVG Volume (30 Days) | 957.9K | ★ 1.1M |
| Earning Date | 02-10-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $12,921,000,000.00 | N/A |
| Revenue This Year | $13.35 | N/A |
| Revenue Next Year | $6.10 | N/A |
| P/E Ratio | $72.33 | ★ N/A |
| Revenue Growth | ★ 16.94 | N/A |
| 52 Week Low | $30.46 | $27.66 |
| 52 Week High | $58.00 | $93.77 |
Technical Indicators
Market Signals| Indicator | GXO | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 61.46 |
| Support Level | $54.95 | $44.85 |
| Resistance Level | $58.00 | $48.93 |
| Average True Range (ATR) | 1.58 | 2.39 |
| MACD | -0.03 | 0.27 |
| Stochastic Oscillator | 76.89 | 91.74 |
Price Performance
Historical ComparisonAbout GXO GXO Logistics Inc.
GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.